| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
73
|
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
42
|
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
40
|
| CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
32
|
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
29
|
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
26
|
| MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
25
|
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
24
|
| TEX41 |
|
testis expressed 41
|
|
|
0.743 |
0.269 |
23
|
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
21
|
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
20
|
| MFF-DT |
|
MFF divergent transcript
|
|
|
0.780 |
0.269 |
19
|
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
17
|
| ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
17
|
| CMAHP |
Q9Y471
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
|
0.805 |
0.346 |
16
|
| ZFPM2-AS1 |
|
ZFPM2 antisense RNA 1
|
|
|
0.736 |
0.385 |
15
|
| VLDLR-AS1 |
|
VLDLR antisense RNA 1
|
|
|
0.821 |
0.115 |
15
|
| LINC00271 |
P0C7V0
|
long intergenic non-protein coding RNA 271
|
|
|
0.769 |
0.192 |
13
|
| TARID |
|
TCF21 antisense RNA inducing promoter demethylation
|
|
|
0.821 |
0.308 |
13
|
| CCNT2-AS1 |
|
CCNT2 antisense RNA 1
|
|
|
0.931 |
0.115 |
12
|
| STARD4-AS1 |
|
STARD4 antisense RNA 1
|
|
|
0.890 |
0.115 |
12
|
| RORA-AS1 |
|
RORA antisense RNA 1
|
|
|
0.931 |
0.115 |
10
|
| LINC01221 |
|
long intergenic non-protein coding RNA 1221
|
|
|
1.000 |
0.038 |
10
|
| SOCAR |
|
serous ovarian cancer associated RNA
|
|
|
0.821 |
0.231 |
10
|